{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T18:44:18Z","timestamp":1767897858589,"version":"3.49.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Chongqing Medical Scientific Research Project","award":["2019MSXM088"],"award-info":[{"award-number":["2019MSXM088"]}]},{"name":"Chongqing Health Commission Project","award":["2022WSJK025"],"award-info":[{"award-number":["2022WSJK025"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,11]]},"abstract":"<jats:p>Anticoagulant therapy is an important measure to prevent stroke or other embolic events in patients with atrial fibrillation (AF). Warfarin, a classical anticoagulant, has a narrow therapeutic range and requires frequent testing and adjustment, making it inconvenient for patients. Additionally, thyroid dysfunction affects the coagulation\u2013fibrinolysis imbalance, with hyperthyroidism increasing the risk of thrombosis and hypothyroidism increasing the risk of bleeding. The study aimed to evaluate the safety and effectiveness of non-vitamin K antagonist oral anticoagulants (NOACs) compared to warfarin in thyroid dysfunction patients. This retrospective study was conducted at 2 academic medical centers in southwestern China, including patients at least 18 years of age with abnormal thyroid function who were initiated on NOACs or warfarin for AF. The primary endpoint was the composite of clinical failure, including mortality, stroke incidence, and major bleeding events. We compared the baseline characteristics and the complex endpoint between NOACs group and warfarin group. A total of 137 patients, 86 receiving NOACs and 51 receiving warfarin were included in the final analysis. At the baseline, the prevalence of chronic heart failure was more common in those receiving warfarin (79.6% vs 55.3%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.005), who also had higher CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc scores (89.8% vs 74.12% in male\u2005\u2265\u20052 or female\u2005\u2265\u20053, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.029). It is found that NOACs had a significantly higher estimated 3-year complex endpoint survival rate compared to warfarin. Stratified analyses show that patients with a body mass index\u2005&lt;\u200524\u2009kg\/m<jats:sup>2<\/jats:sup> being at a higher risk of experiencing endpoint events. NOACs appear to be superior to warfarin in long-term survival rate for patients with AF and thyroid dysfunction, especially in those with body mass index\u2005&lt;\u200524\u2009kg\/m<jats:sup>2<\/jats:sup>.<\/jats:p>","DOI":"10.1097\/md.0000000000043328","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T18:00:15Z","timestamp":1752516015000},"page":"e43328","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["NOACs versus warfarin in people with atrial fibrillation and thyroid dysfunction"],"prefix":"10.1097","volume":"104","author":[{"given":"Lian","family":"Tan","sequence":"first","affiliation":[{"name":"Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, People\u2019s Hospital of Linshui, Sichuan Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biao","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Cardiology, People\u2019s Hospital of Linshui, Sichuan Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiqing","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinting","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Jian","sequence":"additional","affiliation":[{"name":"College of Medical Informatics, Chongqing Medical University, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Song","sequence":"additional","affiliation":[{"name":"Kunming Medical University Haiyuan College, Yunnan Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6352-7893","authenticated-orcid":false,"given":"Huang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250812","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0140-6736(06)68139-7","article-title":"Self monitoring of oral anticoagulation: a systematic review and meta-analysis.","volume":"367","author":"Haneghan","year":"2006","journal-title":"Lancet"},{"key":"R2-20250812","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s12020-009-9185-z","article-title":"Coagulation and fibrinolysis in thyroid dysfunction.","volume":"36","author":"Erem","year":"2009","journal-title":"Endocrine"},{"key":"R3-20250812","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1345\/aph.1G422","article-title":"Effect of Graves\u2019 Disease and methimazole on warfarin anticoagulation.","volume":"40","author":"Busenbark","year":"2006","journal-title":"Ann Pharmacother"},{"key":"R4-20250812","doi-asserted-by":"crossref","first-page":"292468","DOI":"10.1155\/2014\/292468","article-title":"Graves\u2019 Disease and treatment effects on warfarin anticoagulation.","volume":"2014","author":"Howard-Thompson","year":"2014","journal-title":"Case Rep Med"},{"key":"R5-20250812","first-page":"109","article-title":"Use of anticoagulation in thyroid disease.","volume":"45","author":"Polmear","year":"2016","journal-title":"Aust Fam Physician"},{"key":"R6-20250812","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000357578","article-title":"Major haemorrhage during vitamin K antagonist treatment: the influence of thyroid hormone levels.","volume":"3","author":"Debeij","year":"2014","journal-title":"Eur Thyroid J"},{"key":"R7-20250812","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology(ESC)eveloped with the special contribution of the European Heart Rhythm Association(EHRA)of the ESC.","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"R8-20250812","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/j.clinthera.2018.10.009","article-title":"A review of the efficacy and safety profiles of the novel oral anticoagulants in the treatment and prevention of venous thromboembolism.","volume":"40","author":"Coulis","year":"2018","journal-title":"Clin Ther"},{"key":"R9-20250812","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/jth.13323","article-title":"Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH.","volume":"14","author":"Martin","year":"2016","journal-title":"J Thromb Haemost"},{"key":"R10-20250812","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1161\/STROKEAHA.118.020232","article-title":"Effectiveness and safety of oral anticoagulants among nonvalvular atrial fibrillation patients.","volume":"49","author":"Lip","year":"2018","journal-title":"Stroke"},{"key":"R11-20250812","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/CIRCULATIONAHA.114.013243","article-title":"Extracranial systemic embolic events in patients with nonvalvular atrial fibrillation, incidence, risk factors, and outcomes.","volume":"132","author":"Bekwelem","year":"2015","journal-title":"Circulation"},{"key":"R12-20250812","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1056\/NEJM196511112732001","article-title":"Blood coagulation in thyroid dysfunction.","volume":"273","author":"Simone","year":"1965","journal-title":"N Engl J Med"},{"key":"R13-20250812","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1530\/eje.1.01857","article-title":"Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism.","volume":"152","author":"Gullu","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"R14-20250812","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1160\/TH12-07-0525","article-title":"Thrombin-activatable fibrinolysis inhibitor in hypothyroidism and hyperthyroxinaemia.","volume":"109","author":"Verkleij","year":"2013","journal-title":"Thromb Haemost"},{"key":"R15-20250812","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1160\/TH12-07-0496","article-title":"The effect of hyperthyroidism on procoagulant, anticoagulant and fibrinolytic factors: a systematic review and meta-analysis.","volume":"108","author":"Stuijver","year":"2012","journal-title":"Thromb Haemost"},{"key":"R16-20250812","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/jth.13970","article-title":"The influence of thyroid function on the coagulation system and its clinical consequences.","volume":"16","author":"Elbers","year":"2018","journal-title":"J Thromb Haemost"},{"key":"R17-20250812","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF02157446","article-title":"The effect of thyroid function on the prothrombin time response to warfarin in rats.","volume":"13","author":"Lowenthal","year":"1957","journal-title":"Experientia"},{"key":"R18-20250812","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.thromres.2009.09.018","article-title":"The effect of thyroid autoantibodies on warfarin stability.","volume":"126","author":"Dentali","year":"2010","journal-title":"Thromb Res"},{"key":"R19-20250812","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","article-title":"The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.","volume":"39","author":"Steffel","year":"2018","journal-title":"Eur Heart J"},{"key":"R20-20250812","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1530\/EJE-14-0801","article-title":"Prothrombotic changes due to an increase in thyroid hormone levels.","volume":"172","author":"Horacek","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"R21-20250812","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/jth.12626","article-title":"An evaluation of the potential drug interaction between warfarin and levothyroxine.","volume":"12","author":"Wood","year":"2014","journal-title":"J Thromb Haemost"},{"key":"R22-20250812","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM196201112660205","article-title":"Effect of sodium dextrothyroxine in patients receiving anticoagulants.","volume":"266","author":"Owens","year":"1962","journal-title":"N Engl J Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043328","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T17:00:42Z","timestamp":1755018042000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":22,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043328","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]}}}